首页> 美国卫生研究院文献>OncoTargets and therapy >Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance

【2h】

Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance

机译：蛋白酪氨酸激酶6（PTK6）在非小细胞肺癌中的表达及其临床意义及预后意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim:The aim of the study was to validate the expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer (NSCLC), and to evaluate its clinicopathological and prognostic significance.

机译：目的：本研究旨在验证蛋白酪氨酸激酶6（PTK6）在非小细胞肺癌（NSCLC）中的表达，并评估其临床病理和预后意义。

著录项

期刊名称 OncoTargets and therapy
作者
Chao Zhao; Yan Chen; Weiwei Zhang; Jianrong Zhang; Yulian Xu; Wenjie Li; Sunxiao Chen; Anmei Deng;
展开▼
作者单位

展开▼
年(卷),期 2013(6),-1
年度 2013
页码 183–188
总页数 6
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
nonsmall cell lung cancer tyrosine kinase PTK6 target prognosis;

机译：非小细胞肺癌;酪氨酸激酶;PTK6;靶标;预后;

相似文献

外文文献
中文文献
专利

1. Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance [J] . Chao Zhao, Yan Chen, Weiwei Zhang, OncoTargets and therapy . 2013,第4期

机译：蛋白酪氨酸激酶6（PTK6）在非小细胞肺癌中的表达及其临床意义及预后意义
2. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. [J] . Xing J, Wu X, Vaporciyan AA, Cancer: A Journal of the American Cancer Society . 2008,第12期

机译：非小细胞肺癌患者共济失调-毛细血管扩张突变，DNA依赖性蛋白激酶催化亚基和Ku异二聚体调控复合物86-kD亚基表达的预后意义。
3. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance. [J] . Kikuchi J, Kinoshita I, Shimizu Y, Cancer: A Journal of the American Cancer Society . 2010,第12期

机译：非小细胞肺癌中polycomb组蛋白Bmi1 polycomb无名指癌基因和zeste同源物2增强子的独特表达及其临床和临床病理意义。
4. Clinical Significance of VEGF,EGFR and BRCA-1 Expression in Non-Small Cell Lung Cancer [C] . Wang Linhui, Li Yu 5th International Conference on Bioinformatics and Biomedical Engineering . 2011

机译：VEGF，EGFR和BRCA-1在非小细胞肺癌中的表达及其临床意义
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Prognostic Significance of Ataxia-Telangiectasia Mutated DNA-dependent Protein Kinase Catalytic Subunit and Ku Heterodimeric Regulatory Complex 86-kD Subunit Expression in Patients With Nonsmall Cell Lung Cancer [O] . Jinliang Xing, Xifeng Wu, Ara A. Vaporciyan, -1

机译：非小细胞肺癌患者共济失调-毛细血管扩张突变DNA依赖性蛋白激酶催化亚基和Ku异二聚体调节复合物86-kD亚基的表达对预后的意义。
7. Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors [O] . Myung Hee Chang, Hee Kyung Ahn, Jeeyun Lee, 2010

机译：EGFR-酪氨酸激酶抑制剂治疗表皮生长因子受体（EGFR）野生型NONSMALL细胞肺癌患者临床影响

Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance

摘要

著录项

相似文献

相关主题

期刊订阅